News
Oximio announces its sponsorship of the Clinical Research Society of Kenya’s Inaugural Event
Oximio is delighted to announce its sponsorship of the inaugural launch of the Clinical Research Society of Kenya (CRSK) on 8th June in Nairobi. The CRSK is a non-profit organization set up to represent the clinical research community in Kenya. Acting as a...
Oximio Hungary Receives GMP and MIA Certification
We are delighted to announce that Oximio Hungary has been granted Good Manufacturing Practice (GMP) and Manufacturing and Importation Authorisation (MIA) certification. The accreditations provide assurance to our customers that we meet the rigorous regulatory...
In response to the war, Oximio Ukraine implemented our business continuity plan
Oximio is a global end-to-end logistics provider for clinical trials with over 19 years of experience in the industry. Despite the brutal impacts on our Ukrainian founding country in the past year, this has inspired us to strive to deliver not only for the company but...
Oximio Ukraine is represented at CTS Executive Board at EBA
We are delighted to announce that Oximio Ukraine is represented at the Clinical Trials Subcommittee (CTS) Executive Board at the European Business Association (EBA). Established in 1999, the EBA provides a forum in which members can discuss and find solutions to...
Meet Oximio at GCSG US 2023
Global Clinical Supplies Group (GCSG) US Conference 23 – 26 April 2023, Orlando (USA) Global Clinical Supplies Group (GSCG) will take place in Orlando (USA), bringing together clinical supply professionals. Each year, over 350 clinical supply professionals...
Oximio support for Türkiye earthquake disaster
Oximio Community expresses its deepest condolences and supports the communities affected by the earthquake in Türkiye. We can confirm that our Oximio facility in Türkiye has not been affected, however we feel the pain and understand the devastation caused by this...
Oximio Israel excels in securing import licenses for unlicensed medication
We are delighted to announce that Oximio Israel has been successfully awarded yet another import license for Compassionate use program in January 2023. “Compassionate use” allows for a patient outside of clinical trials with a serious or life-threatening disease to...
New bonded depot in Serbia opens
We are delighted to share that expansion of our global bonded depot network continues. We have successfully received the bonded depot license this week for our Serbia facility. This opens a route for imports of bulk shipments and distribution from our depot in Serbia...
Oximio expands patient centricity services in Israel
As Oximio patient centricity services continue to expand, we are delighted to announce that the first home healthcare visit in Israel took place week commencing 9th of January 2023.The services allow for the nurses to collect the bio-samples from the patients’...